Regulation & law · 19/11/20261 min read
SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for Shareholders
Summary
Amparo Law Firm PLLC, through its Amparo Investor Rights practice, is investigating whether $23.50 per share is the best price Surgery Partners, Inc. (Nasdaq: SGRY) shareholders could obtain, whether the board ran a sale process designed to get it, and whether shareholders may have claims for...